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INTRODUCTION
Now a day, the entire pharmaceutical industry is faced with the challenge of increasing productivity and innovation. The major hurdles are the increasing costs of research and development and a simultaneous stagnating number of new chemical entities (NCEs).
For several thousand years, man has used herbs and potions as medicines, but it is only since the mid-nineteenth century that serious efforts were made to isolate and purify the active principles of these remedies and Medicinal chemistry received further boost in 1940 as pharmacology, which until then had been dominated by physiology, became increasingly biochemical in character with new understanding of the role of enzymes and cell receptors. Successful drug synthesis depends upon the ability to identify new chemical entities that have potential to treat diseases in a safe and efficient manner.
In order to address the need for new MAO inhibitors with less side effects, we can aim compounds previously discovered for their potential as MAOIs. Among them, safinamide was reported to be a potent anti-MAO B agent, and milacemide, which was found to be a potent MAO inhibitor and a prodrug for glycine [1-5, 32, 33] .
2-Phenoxyacetamide
According to Wei et al., several substitutions are possible at R1-R5 and which can affect the MAO inhibitory activity of enzyme and gives a variety of compounds with satisfactory MAO activity. Results of this study show that most of the synthesized compounds are potent and selective inhibitors of MAO-A rather than of MAO-B. [6] [7] [8] [9] 34] For the QSAR study to target MAO enzyme selection of series is based on IC 50 value. The ratio of Maximum and minimum IC50 value should be ≥ 1000. The following series of Phenoxyacetamide is selected on the same basis.
Selection of series of Phenoxyacetamide

-First eighteen compounds
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The discovery of a lead compound is assumed to be the most complicated aspect of the drug scheming process. Once a lead compound for a novel therapeutically vigorous drug has been revealed, it is additionally subjected to effectual toxicological studies so that its worth and protection can be thoroughly evaluated before the instigation of its clinical trials [35] .
MATERIALS AND METHODS
A series of phenoxyacetamide derivatives was selected from a reported article which presented the synthesis of novel derivatives of this compound and evaluated their MAO A and MAO B inhibitory activity. Structure build-up, physico-chemical property determination, and sequential multiple regression analysis was performed on the reported series. In QSAR study all computational work was performed using ChemDraw2D Ultra8.0 and Chem3D Ultra 8.0 software core i3 Duo processor and a windows7 Operating system. The regression analysis was carried out using VALSTAT software.
EXPERIMENTAL WORK
QSAR Study of Selected Series of Compounds
The QSAR paradigm is based on the assumption that there is an underlying relationship between the molecular structure and biological activity. On this assumption QSAR attempts to establish a correlation between various molecular properties of a set of molecules with their experimentally known biological activity. Determination of QSAR generally proceeds as follows:
Biological Activity Calculation
Several substitutions were carried out on Phenoxyacetamide ring and 28 compounds were synthesized and their inhibitory potency towards monoamine oxidases A (MAO-A) and B (MAO-B) were evaluated using enzyme and cancer cell lysate. 2-(4 Methoxyphenoxy) acetamide and (2-(4-((prop-2ynylimino) methyl)phenoxy) acetamide were successfully identified as the most specific MAO-A inhibitor, and the most potent MAO-A/-B inhibitor, respectively [10] [11] [12] [13] [14] . The MAO A inhibitory activity data IC 50 values were determined against MAO A subunit of synthesized compounds of series were converted to pIC 50 . The MAO A inhibitory activity of synthesized compounds was determined in terms of MIC against isoenzyme. The MIC is expressed as micro Molar concentration(C) and converted intolog C values (called as biological activity). These dependent data are tabulated in the Tables 2 and 3 . 
Determination of Molecular Descriptors
The structures of the remaining twenty-four compounds were fabricated by means of Chemdraw Ultra 7.0.1 of Chemoffice Ultra 7.0.1 suite software, which is a product of Cambridge soft corporation, U.S.A. These structures were then saved in MDL (mol) format which is followed by energy minimization using Chem3D ultra 7.0.1 by the means of MM2 (Molecular Mechanics) force fields and followed by MOPAC-Closed shell (AM-1) pro force fields using 0.100 as root mean square gradient.
The minimization was executed until the Root Mean Square (RMS) gradient value reaches a value smaller than 0.1kcal / mol. The minimized molecules were subjected to reoptimization via Austin model-1 method until RMS gradient attains a value smaller than 0.0001 kcal / mol A° using MOPAC. The geometry optimization of the lowest energy structure was carried out using Eigenvector Following (EF) routine. The descriptor values for all the molecules were calculated using "compute properties" module of program [15] [16] [17] [18] [19] [20] [21] .
The properties of all these compounds were simultaneously computed using Chem3D ultra. Subsequently, all these calculated properties were arranged in Microsoft Excel 2007 sheet and subjected to the statistical software VALSTAT.
Selection of Training and Test Set:
The compounds were divided into training and test sets by random selection. The training set was used for the model development and the test set was used for cross validation of QSAR model developed by the training set. 
QSAR Models Development
A set of 28 compounds were selected from the report obtained from the MAO-A inhibitory activity and divided as training set and test set each consisting of 22 and 6 compounds respectively by random selection method. The descriptors were used in this study are given along with values in the 
B. Internal validation:
The VALSTAT software automatically performed leave one out methods to get best model to increase biological activity. QSAR model was developed and this model was used to predict the biological activity of test set of compounds.
RESULT AND DISCUSSION
Statistical data of 5 models given in table 6 . For all models training set (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 19, 22, 23, 24, 25, 26, 27, 28) of compounds and test set (1, 16, 17, 18, 20, 21) of compounds were taken randomly by VALSTAT software computer program and intercorrelation limit was used at 0.5. Out of all 5 models, model 5 was selected based on high value of stastical data Q2, r2 and r2 prediction. Model no. 5 shows descriptors partition coefficient, stretch energy and shape coefficient are positively correlated with biological activity of compounds. When increased the value of both descriptors it will be increased biological activity of compounds.
Final correlation matrix is given in figure 1 and 2 respectively. Graph for test set of compounds plotted between observed values and predicted values is given in figure 3 . 
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